Overview

Study of AMG 706 in Subjects With Advanced Gastrointestinal Stromal Tumors (GISTs)

Status:
Completed
Trial end date:
2008-06-01
Target enrollment:
Participant gender:
Summary
This study will determine the safety and effectiveness of AMG 706 in patients with advanced GIST.
Phase:
Phase 2
Details
Lead Sponsor:
Amgen
Treatments:
Motesanib diphosphate
Niacinamide